---
$id: https://graph.org.ai/products/commodity/51131809
$type: Product
source: UNSPSC
code: "51131809"
title: "Calcium dobesilate"
class: "51131800"
classTitle: "Coagulants and systemic hemostatic agents"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Calcium dobesilate

**UNSPSC Code**: 51131809
**Class**: [Coagulants and systemic hemostatic agents](Coagulants and systemic hemostatic agents.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a benzenesulfonates and anti-hemorrhagic with the molecular formula 2C6H5O5S.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5921X1560Q, chemically known as 2,5-dihydroxybenzenesulfonic acid calcium salt but generally known as calcium dobesilate, which bears US NIH Compound Identifier 29963. European Medicines Agency schedules Calcium dobesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06051MIG. World Health Organization schedules calcium dobesilate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule calcium dobesilate under HS 29089910 and SITC 51244. As of Q4 2014, CALCIUM DOBESILATE remains the US FDA Preferred Term for this commodity. SMILES: C1=CC(=C(C=C1O)S(=O)(=O)[O-])O.C1=CC(=C(C=C1O)S(=O)(=O)[O-])O.[CA+2].

